Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.99 CAD | +3.82% | -14.57% | +3.10% |
05-17 | XORTX Therapeutics Reprices Warrants Connected With U.S. IPO | MT |
05-17 | XORTX Therapeutics Brief: Says Repriced Balance of Warrants Issued in Connection with October 2021 US IPO | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+3.10% | 6.34M | |
+16.93% | 123B | |
+17.01% | 111B | |
-7.23% | 23.63B | |
+3.00% | 22.58B | |
-14.29% | 17.26B | |
-6.79% | 17.6B | |
-37.63% | 17.61B | |
+2.17% | 13.55B | |
+24.42% | 11.34B |
- Stock Market
- Equities
- XRTX Stock
- News XORTX Therapeutics Inc.
- XORTX Submits Orphan Drug Designation Application to European Medicines Agency to Treat Progressive Kidney Disease